Company Profile - vTv Therapeutics Inc

Introduction

vTv Therapeutics Inc (vTv) is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company’s pipeline product portfolio includes small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer. Its products include azeliragon, TTP399, TTP273, HPP593 and HPP737. vTv utilizes TTP translational technology to deliver clinical drug candidates against biological targets including protein-protein interactions, receptor modulators and enzyme inhibitors. The company collaborates with other pharmaceutical companies to discover and develop small molecule therapeutics for the treatment of major diseases. vTv is headquartered in High Point, North Carolina, the US.